Skip Navigation
Investor Login(opens in new window)

healthcare News & Insights

Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization

Filter

Categories

  • All
  • Arsenal News
  • Portfolio News
  • Insights & Perspectives

Year

  • All
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Portfolio News

Certara Launches Non-Animal Navigator™ Solution

Apr. 14, 2025

Portfolio News

Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization

Apr. 14, 2025

Arsenal News

Rancho Appoints Marc Ginsky as CEO

Mar. 31, 2025

Portfolio News

Nagaraja "Sri" Srivatsan Appointed CEO of Endpoint Clinical

Mar. 20, 2025

Portfolio News

Clario to Acquire WCG's eCOA Business

Mar. 10, 2025

Portfolio News

OncoHealth Appoints Jon Maack as CEO

Feb. 11, 2025

Portfolio News

Knowtion Health Appoints Erica Tingley as CFO

Jan. 21, 2025

Portfolio News

WCG Appoints Stacey Yount as Chief Growth Officer

Dec. 02, 2024

Arsenal News

Arsenal Adds Joshua Schultz as an Operating Partner

Nov. 04, 2024

Portfolio News

3DR Labs Appoints Michael Jackman as CEO

Nov. 04, 2024

Portfolio News

hc1 Acquires Accumen

Oct. 22, 2024

Portfolio News

Arsenal to Acquire Knowtion Health

Aug. 22, 2024

Portfolio News

Certara to Acquire Chemaxon

Jul. 09, 2024

Portfolio News

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal

Jun. 04, 2024

Arsenal News

Arsenal Forms Digital, AI, and Data Analytics Group

Mar. 14, 2024

Portfolio News

Fortrea Signs Agreement to Divest Endpoint and Patient Access to Arsenal

Mar. 11, 2024

Portfolio News

Certara Acquires Applied BioMath

Dec. 14, 2023

Portfolio News

Certara Acquires Formedix

Oct. 10, 2023

Portfolio News

Certara Acquires Vyasa

Jan. 04, 2023

Portfolio News

Certara Announces the Completion of Arsenal's Investment

Dec. 08, 2022

Portfolio News

Lumanity Expands Life Science Consulting Capability with Acquisition of Clarion

Nov. 08, 2022

Portfolio News

Arsenal Increases Investment in Certara with $449M Stock Purchase

Nov. 07, 2022

Insights & Perspectives

Cell Press: The Gripping Story of Integrins

Sep. 30, 2022

Portfolio News

Lumanity Acquires Endpoint Outcomes

Jun. 14, 2022

Portfolio News

WCG Appoints New Chief Financial and Administrative Officer and Chief Technology Officer

May 31, 2022

Portfolio News

Epic Sciences Completes First Close of Series F Financing

May 31, 2022

Arsenal News

Autism Impact Fund and Arsenal Form Strategic Partnership

May 24, 2022

Portfolio News

WCG Appoints Sam Srivastava as Chief Executive Officer

May 18, 2022

Portfolio News

OncoHealth Secures Strategic Investments from Arsenal Capital Partners & McKesson Corporation

May 09, 2022

Portfolio News

Lumanity Acquires Innovative Edge

Mar. 30, 2022

Portfolio News

Introducing Lumanity - An Organization Dedicated to Accelerating and Optimizing Access to Medical Advances

Mar. 14, 2022

Portfolio News

Arsenal’s Value Demonstration Business Acquires Zipher Medical Affairs

Jan. 10, 2022

Portfolio News

CellCarta Acquires Biogazelle

Dec. 14, 2021

Portfolio News

Arsenal’s Value Demonstration Business Acquires Cyan Health

Dec. 12, 2021

Portfolio News

Value Demonstration Acquires Guidemark Health

Nov. 02, 2021

Portfolio News

Arsenal Completes Sale of BioIVT to Linden

Oct. 05, 2021

Portfolio News

CellCarta Acquires Artificial Intelligence-Based Pathology Leader Reveal Biosciences

May 11, 2021

Insights & Perspectives

A New Era of Telehealth

Mar. 24, 2021

Portfolio News

Best Value Healthcare Acquires MAXhealth

Mar. 12, 2021

Portfolio News

Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta

Jan. 26, 2021

Portfolio News

Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories

Jan. 12, 2021

Portfolio News

Caprion-HistoGeneX Acquires Clinical Logistics a Virtual Central Specimen Management CRO

Jan. 07, 2021

Insights & Perspectives

The Upside to the COVID-19 Pandemic: Exposing the Dysfunction of Fee-for-Service Reimbursement, with Mark McClellan, MD

Dec. 30, 2020

Insights & Perspectives

Mark McClellan Discusses the COVID-19 Vaccine Distribution on CNBC

Dec. 10, 2020

Insights & Perspectives

Wright Lassiter Recognized for His Exceptional Leadership Through the COVID-19 Pandemic

Dec. 03, 2020

Portfolio News

Arsenal Acquires Best Value Healthcare

Nov. 17, 2020

Portfolio News

symplr to acquire TractManager

Oct. 23, 2020

Insights & Perspectives

Clear + Vivid Podcast: James Rothman – on Discovering the ‘FedEx trucks’ in our Cells

Oct. 20, 2020

Insights & Perspectives

Robert Accordino Named a Top 25 Emerging Leader by Modern Healthcare

Oct. 15, 2020

Arsenal News

Arsenal Capital Partners Adds Dr. Richard Eglen as Senior Advisor to its Healthcare Team

Sep. 23, 2020

Insights & Perspectives

Arsenal Senior Advisor, Scott Hayworth, Named to Crain's New York Business's 2020 Notable in Health Care List

Aug. 18, 2020

Portfolio News

Arsenal Capital Partners Completes £182 Million Acquisition of Cello Health

Aug. 11, 2020

Arsenal News

Arsenal Capital Partners Announces Two New Investment Partners; Dr. John Mattison Named Operating Partner & Chief Medical Information Officer

Jul. 13, 2020

Insights & Perspectives

Dr. John Mattison Talks about the Critical Role of Data in Driving Healthcare Innovation

Jul. 10, 2020

Insights & Perspectives

Don Deieso & PharmaVOICE: A New Era of Clinical Trials

Jun. 16, 2020

Portfolio News

Arsenal Completes BresMed Acquisition; First Step to the Creation of a New Science- and Technology-Driven Value Demonstration Group

Feb. 26, 2020

Portfolio News

Leonard Green & Partners Leads Recapitalization of WCG in Partnership with Arsenal Capital Partners

Nov. 14, 2019

Arsenal News

Arsenal Capital Partners Announces Addition of Mike Bernstein as Operating Partner to its Healthcare Team

Aug. 21, 2019

Portfolio News

Caprion Biosciences and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development

Jul. 31, 2019

Portfolio News

Accumen Acquires Halfpenny Technologies

Jun. 19, 2019

Portfolio News

Arsenal Announces Acquisition of Hopebridge

May 06, 2019

Portfolio News

Arsenal Capital Partners Acquires Accumen

Jan. 17, 2019

Portfolio News

Arsenal announces sale of Certara, retains significant minority investment stake

Jul. 11, 2017

Portfolio News

TractManager Appoints Trace Devanny Chief Executive Officer

Oct. 27, 2016

Arsenal News

Arsenal Capital Partners Hires Spaight As Healthcare Operating Partner

Oct. 16, 2016

Portfolio News

Arsenal Capital-Led Investor Group Recapitalizes WIRB-Copernicus Group

Aug. 18, 2016

Portfolio News

Arsenal Capital Partners Invests In BioreclamationIVT

Jan. 19, 2016

This site uses cookies, including third-party cookies, to enable website functionality and analyze the performance of our site. Our cookies do not store any personal or confidential information about you, and you can delete and block cookies via your browser settings at any time. By continuing to use our website you accept our use of cookies.

Find out more about cookies